Global Oral Antiviral Medications for COVID-19 market growth is projected to reach  US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Oral Antiviral Medications for COVID-19 Market Trends and Analysis 2025-31

The global Oral Antiviral Medications for COVID-19 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Lagevrio and Paxlovid have both been found to be effective in treating mild to moderate COVID-19 in adults aged 18 years of age and older, who do not require supplemental oxygen, and who are at increased risk of progression to hospitalisation. The advantage of these oral medications is that many people will be able to receive treatment for COVID-19 in their own homes without the need to travel to hospital for treatment as an inpatient. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Oral Antiviral Medications for COVID-19 Industry Forecast looks at past sales and reviews total world Oral Antiviral Medications for COVID-19 sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Antiviral Medications for COVID-19 sales for 2025 through 2031. With Oral Antiviral Medications for COVID-19 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Antiviral Medications for COVID-19 industry. This Insight Report provides a comprehensive analysis of the global Oral Antiviral Medications for COVID-19 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Antiviral Medications for COVID-19 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oral Antiviral Medications for COVID-19 market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Antiviral Medications for COVID-19 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Antiviral Medications for COVID-19. This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antiviral Medications for COVID-19 market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Tablet &nbsp;&nbsp;&nbsp; Capsule Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinics This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Shionogi &nbsp;&nbsp;&nbsp; Frontier Biotechnologies &nbsp;&nbsp;&nbsp; Simcere Pharmaceutical &nbsp;&nbsp;&nbsp; Guangdong Zhongsheng Key Questions Addressed in this Report What is the 10-year outlook for the global Oral Antiviral Medications for COVID-19 market? What factors are driving Oral Antiviral Medications for COVID-19 market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Oral Antiviral Medications for COVID-19 market opportunities vary by end market size? How does Oral Antiviral Medications for COVID-19 break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Oral Antiviral Medications for COVID-19 Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Oral Antiviral Medications for COVID-19 by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Oral Antiviral Medications for COVID-19 by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Oral Antiviral Medications for COVID-19 Segment by Type &nbsp;2.2.1 Tablet &nbsp;2.2.2 Capsule &nbsp;2.3 Oral Antiviral Medications for COVID-19 Sales by Type &nbsp;2.3.1 Global Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Oral Antiviral Medications for COVID-19 Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Oral Antiviral Medications for COVID-19 Sale Price by Type (2020-2025) &nbsp;2.4 Oral Antiviral Medications for COVID-19 Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinics &nbsp;2.5 Oral Antiviral Medications for COVID-19 Sales by Application &nbsp;2.5.1 Global Oral Antiviral Medications for COVID-19 Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Oral Antiviral Medications for COVID-19 Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Oral Antiviral Medications for COVID-19 Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Oral Antiviral Medications for COVID-19 Breakdown Data by Company &nbsp;3.1.1 Global Oral Antiviral Medications for COVID-19 Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Oral Antiviral Medications for COVID-19 Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Oral Antiviral Medications for COVID-19 Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Oral Antiviral Medications for COVID-19 Revenue by Company (2020-2025) &nbsp;3.2.2 Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Oral Antiviral Medications for COVID-19 Sale Price by Company &nbsp;3.4 Key Manufacturers Oral Antiviral Medications for COVID-19 Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Oral Antiviral Medications for COVID-19 Product Location Distribution &nbsp;3.4.2 Players Oral Antiviral Medications for COVID-19 Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Oral Antiviral Medications for COVID-19 by Geographic Region &nbsp;4.1 World Historic Oral Antiviral Medications for COVID-19 Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Oral Antiviral Medications for COVID-19 Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Oral Antiviral Medications for COVID-19 Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Oral Antiviral Medications for COVID-19 Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Oral Antiviral Medications for COVID-19 Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Oral Antiviral Medications for COVID-19 Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Oral Antiviral Medications for COVID-19 Sales Growth &nbsp;4.4 APAC Oral Antiviral Medications for COVID-19 Sales Growth &nbsp;4.5 Europe Oral Antiviral Medications for COVID-19 Sales Growth &nbsp;4.6 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales Growth 5 Americas &nbsp;5.1 Americas Oral Antiviral Medications for COVID-19 Sales by Country &nbsp;5.1.1 Americas Oral Antiviral Medications for COVID-19 Sales by Country (2020-2025) &nbsp;5.1.2 Americas Oral Antiviral Medications for COVID-19 Revenue by Country (2020-2025) &nbsp;5.2 Americas Oral Antiviral Medications for COVID-19 Sales by Type (2020-2025) &nbsp;5.3 Americas Oral Antiviral Medications for COVID-19 Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Oral Antiviral Medications for COVID-19 Sales by Region &nbsp;6.1.1 APAC Oral Antiviral Medications for COVID-19 Sales by Region (2020-2025) &nbsp;6.1.2 APAC Oral Antiviral Medications for COVID-19 Revenue by Region (2020-2025) &nbsp;6.2 APAC Oral Antiviral Medications for COVID-19 Sales by Type (2020-2025) &nbsp;6.3 APAC Oral Antiviral Medications for COVID-19 Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Oral Antiviral Medications for COVID-19 by Country &nbsp;7.1.1 Europe Oral Antiviral Medications for COVID-19 Sales by Country (2020-2025) &nbsp;7.1.2 Europe Oral Antiviral Medications for COVID-19 Revenue by Country (2020-2025) &nbsp;7.2 Europe Oral Antiviral Medications for COVID-19 Sales by Type (2020-2025) &nbsp;7.3 Europe Oral Antiviral Medications for COVID-19 Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Oral Antiviral Medications for COVID-19 by Country &nbsp;8.1.1 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Oral Antiviral Medications for COVID-19 &nbsp;10.3 Manufacturing Process Analysis of Oral Antiviral Medications for COVID-19 &nbsp;10.4 Industry Chain Structure of Oral Antiviral Medications for COVID-19 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Oral Antiviral Medications for COVID-19 Distributors &nbsp;11.3 Oral Antiviral Medications for COVID-19 Customer 12 World Forecast Review for Oral Antiviral Medications for COVID-19 by Geographic Region &nbsp;12.1 Global Oral Antiviral Medications for COVID-19 Market Size Forecast by Region &nbsp;12.1.1 Global Oral Antiviral Medications for COVID-19 Forecast by Region (2026-2031) &nbsp;12.1.2 Global Oral Antiviral Medications for COVID-19 Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Oral Antiviral Medications for COVID-19 Forecast by Type (2026-2031) &nbsp;12.7 Global Oral Antiviral Medications for COVID-19 Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Pfizer &nbsp;13.1.1 Pfizer Company Information &nbsp;13.1.2 Pfizer Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.1.3 Pfizer Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Pfizer Main Business Overview &nbsp;13.1.5 Pfizer Latest Developments &nbsp;13.2 Merck &nbsp;13.2.1 Merck Company Information &nbsp;13.2.2 Merck Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.2.3 Merck Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Merck Main Business Overview &nbsp;13.2.5 Merck Latest Developments &nbsp;13.3 Shionogi &nbsp;13.3.1 Shionogi Company Information &nbsp;13.3.2 Shionogi Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.3.3 Shionogi Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Shionogi Main Business Overview &nbsp;13.3.5 Shionogi Latest Developments &nbsp;13.4 Frontier Biotechnologies &nbsp;13.4.1 Frontier Biotechnologies Company Information &nbsp;13.4.2 Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.4.3 Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Frontier Biotechnologies Main Business Overview &nbsp;13.4.5 Frontier Biotechnologies Latest Developments &nbsp;13.5 Simcere Pharmaceutical &nbsp;13.5.1 Simcere Pharmaceutical Company Information &nbsp;13.5.2 Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.5.3 Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Simcere Pharmaceutical Main Business Overview &nbsp;13.5.5 Simcere Pharmaceutical Latest Developments &nbsp;13.6 Guangdong Zhongsheng &nbsp;13.6.1 Guangdong Zhongsheng Company Information &nbsp;13.6.2 Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Product Portfolios and Specifications &nbsp;13.6.3 Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Guangdong Zhongsheng Main Business Overview &nbsp;13.6.5 Guangdong Zhongsheng Latest Developments 14 Research Findings and Conclusion

Report	Global Oral Antiviral Medications for COVID-19 Market Growth 2025-2031
Selected License	Multi ID: LPI13605

Buyer Information

Order Summary